Jim Frates

Director of Finance/CFO at AMYLYX PHARMACEUTICALS, INC.

Net worth: 4 M $ as of 31/05/2026

58 year

75 connections

Consumer Services

Commercial Services

Health Technology

Profile

James M.
Frates is currently a Trustee at St. Francis House and Chief Financial Officer at Amylyx Pharmaceuticals, Inc. Formerly, Mr. Frates was an Independent Director at SAGE Therapeutics, Inc. from 2014 to 2025, Chief Financial Officer & Senior Vice President at Alkermes Plc from 2011 to 2021, Vice President-Investment Banking at Robertson Stephens & Co. from 1996 to 1998, Director at GPC Biotech AG from 2004 to 2009, and National Director at The Association of Bioscience Financial Officers from 2004 to 2009.
Mr. Frates also served as Treasurer & Trustee at St. Paul's School and Roxbury Latin School.
Education includes an MBA from Harvard Business School in 1996 and undergraduate studies at Harvard College.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
AMYLYX PHARMACEUTICALS, INC. 0.24%	10/04/2026	261,628 ( 0.24% )	4 M $	31/05/2026

Jim Frates active positions

Companies	Position	Start
AMYLYX PHARMACEUTICALS, INC.	Director of Finance/CFO	01/01/2021
St. Francis House St. Francis House Personnel ServicesCommercial Services Provides rehabilitation services	Director/Board Member	-

All active positions of Jim Frates

Former positions of Jim Frates

Companies	Position	End
SAGE THERAPEUTICS, INC.	Director/Board Member	31/07/2025
ALKERMES PLC	Director of Finance/CFO	11/01/2021
GPC Biotech AG GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs	Director/Board Member	01/06/2009
The Association of Bioscience Financial Officers The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers	Director/Board Member	01/01/2009
Robertson Stephens & Co. Robertson Stephens & Co. Investment Banks/BrokersFinance Provides brokerage services	Corporate Officer/Principal	01/06/1998

See the detail of Jim Frates's experience

Training of Jim Frates

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jim Frates's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
GPC Biotech AG GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes new anticancer drugs	Commercial Services
Robertson Stephens & Co. Robertson Stephens & Co. Investment Banks/BrokersFinance Provides brokerage services	Finance
The Association of Bioscience Financial Officers The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers	Commercial Services
St. Francis House St. Francis House Personnel ServicesCommercial Services Provides rehabilitation services	Commercial Services
St. Paul's School St. Paul's School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Alkermes Plc Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer	Health Technology
SAGE Therapeutics, Inc. SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders	Health Technology
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard College Harvard College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Roxbury Latin School Roxbury Latin School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Amylyx Pharmaceuticals, Inc. Amylyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products to cure neurodegenerative diseases	Health Technology